 |
 | -20°C |  | Ambient | | Note: Store and Ship conditions may differ. | | See Key |
|
 |
 |
| |  | Cat. No. 559393 | |
4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole, HCl Amber solid. PROTECT FROM LIGHT. HYGROSCOPIC. A water-soluble form of the potent p38 MAP kinase inhibitor SB 202190 (Cat. No. 559388). Purity: ≥97% by HPLC. |
| Related information for this product is available: | |
| |
EMD Chemicals Inc. USD list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.
| DMSO or slightly soluble in H2O (0.5 mg/ml) | C20H14FN3O · HCl | 367.8 |
 | - Patrick Michl, et al. (2005) CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness. Cancer Cell 7, 521-532.
- Yung-Luen Yu, et al. (2005) MAP kinase-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. Journal of Biological Chemistry 280, 29533-29542.
|  |
|
|